26 May 2013
Keywords: Hospira, Javelin, Durect, Loan, M&D, License, Posidur, Bupivacine
Article | 08 June 2010
Javelin Pharmaceuticals, which last week initiated legal action to enforce a merger and loan agreement with fellow USA-based Hospira (The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 June 2010
7 June 2010
24 May 2013
© 2013 thepharmaletter.com